Revisiting cardiac injury during acute heart failure: Further characterization and a possible target for therapy

American Journal of Cardiology

Volumn 115, Issue 1, 2015, Pages 141-146

  Collins, Sean P ^a   Pang, Peter S ^b   Butler, Javed ^c   Fonarow, Gregg ^d   Metra, Marco ^e   Gheorghiade, Mihai ^f  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRESCIA   (Italy)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NESIRITIDE; NEUROHORMONE; RELAXIN; TROPONIN;

ACUTE HEART FAILURE; ADAPTATION; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BLOOD FLOW; FORWARD HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART STRESS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; PHARMACEUTICAL CARE; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TACHYCARDIA; TREATMENT OUTCOME; ACUTE DISEASE; HEART FAILURE; HEART MUSCLE; PATHOLOGY; PROGNOSIS;

ACUTE DISEASE; HEART FAILURE; HOSPITALIZATION; HUMANS; MYOCARDIUM; PROGNOSIS;

EID: 84916205129     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.09.040     Document Type: Editorial

References (29)

1. F. Follath, M.B. Yilmaz, J.F. Delgado, J.T. Parissis, R. Porcher, E. Gayat, N. Burrows, A. McLean, F. Vilas-Boas, and A. Mebazaa Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) Intensive Care Med 37 2011 619 626
2. A.P. Maggioni, U. Dahlstrom, G. Filippatos, O. Chioncel, M. Crespo Leiro, J. Drozdz, F. Fruhwald, L. Gullestad, D. Logeart, G. Fabbri, R. Urso, M. Metra, J. Parissis, H. Persson, P. Ponikowski, M. Rauchhaus, A.A. Voors, O.W. Nielsen, F. Zannad, and L. Tavazzi EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 15 2013 808 817
3. M. Gheorghiade, L. De Luca, G.C. Fonarow, G. Filippatos, M. Metra, and G.S. Francis Pathophysiologic targets in the early phase of acute heart failure syndromes Am J Cardiol 96 2005 11G 17G
4. J.P. Lassus, K. Siirila-Waris, M.S. Nieminen, J. Tolonen, T. Tarvasmaki, K. Peuhkurinen, J. Melin, K. Pulkki, and V.P. Harjola Long-term survival after hospitalization for acute heart failure-differences in prognosis of acutely decompensated chronic and new-onset acute heart failure Int J Cardiol 168 2013 458 462
5. C.M. O'Connor, and M. Fiuzat Lessons learned from clinical trials in acute heart failure: phase 3 drug trials Heart Fail Clin 7 2011 451 456
6. P.S. Pang, and M. Gheorghiade A review of phase II acute heart failure syndromes clinical trials Heart Fail Clin 7 2011 441 450
7. A.P. Ambrosy, P.S. Pang, S. Khan, M.A. Konstam, G.C. Fonarow, B. Traver, A.P. Maggioni, T. Cook, K. Swedberg, J.C. Burnett Jr., L. Grinfeld, J.E. Udelson, F. Zannad, and M. Gheorghiade Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial Eur Heart J 34 2013 835 843
8. M. Metra, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg, P. Ponikowski, E. Unemori, A.A. Voors, K.F. Adams Jr., M.I. Dorobantu, L. Grinfeld, G. Jondeau, A. Marmor, J. Masip, P.S. Pang, K. Werdan, M.F. Prescott, C. Edwards, S.L. Teichman, A. Trapani, C.A. Bush, R. Saini, C. Schumacher, T. Severin, and J.R. Teerlink Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes J Am Coll Cardiol 61 2013 196 206
9. C.M. O'Connor, M. Fiuzat, C. Lombardi, K. Fujita, G. Jia, B.A. Davison, J. Cleland, D. Bloomfield, H.C. Dittrich, P. Delucca, M.M. Givertz, G. Mansoor, P. Ponikowski, J.R. Teerlink, A.A. Voors, B.M. Massie, G. Cotter, and M. Metra Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study Circ Heart Fail 4 2011 724 732
10. J.L. Januzzi Jr., G. Filippatos, M. Nieminen, and M. Gheorghiade Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section Eur Heart J 33 2012 2265 2271
11. G.M. Felker, V. Hasselblad, W.H. Tang, A.F. Hernandez, P.W. Armstrong, G.C. Fonarow, A.A. Voors, M. Metra, J.J. McMurray, J. Butler, G.M. Heizer, K. Dickstein, B.M. Massie, D. Atar, R.W. Troughton, S.D. Anker, R.M. Califf, R.C. Starling, and C.M. O'Connor Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study Eur J Heart Fail 14 2012 1257 1264
12. S. Masson, I. Anand, C. Favero, S. Barlera, T. Vago, F. Bertocchi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J.N. Cohn, and R. Latini Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials Circulation 125 2012 280 288
13. W.F. Peacock, T. De Marco, G.C. Fonarow, D. Diercks, J. Wynne, F.S. Apple, and A.H. Wu Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
14. J.J. You, P.C. Austin, D.A. Alter, D.T. Ko, and J.V. Tu Relation between cardiac troponin I and mortality in acute decompensated heart failure Am Heart J 153 2007 462 470
15. E.R. Perna, S.M. Macin, J.P. Cimbaro Canella, P.M. Alvarenga, N.G. Rios, R. Pantich, N. Augier, E.F. Farias, E. Jantus, M. Brizuela, and F. Medina Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure Int J Cardiol 99 2005 253 261
16. M. Metra, L. Bettari, F. Pagani, V. Lazzarini, C. Lombardi, V. Carubelli, G. Bonetti, S. Bugatti, G. Parrinello, L. Caimi, G.M. Felker, and L. Dei Cas Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation Clin Res Cardiol 101 2012 663 672
17. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, and G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
18. M.H. Hessel, E.C. Michielsen, D.E. Atsma, M.J. Schalij, E.J. van der Valk, W.H. Bax, W.T. Hermens, M.P. van Dieijen-Visser, and A. van der Laarse Release kinetics of intact and degraded troponin I and T after irreversible cell damage Exp Mol Pathol 85 2008 90 95
19. J. Feng, B.J. Schaus, J.A. Fallavollita, T.C. Lee, and J.M. Canty Jr. Preload induces troponin I degradation independently of myocardial ischemia Circulation 103 2001 2035 2037
20. E.R. Perna, S.M. Macin, J.P. Canella, N. Augier, J.L. Stival, J.R. Cialzeta, A.E. Pitzus, E.H. Garcia, R. Obregon, M. Brizuela, and A. Barbagelata Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification Circulation 110 2004 2376 2382
21. Y. Sato, T. Kita, Y. Takatsu, and T. Kimura Biochemical markers of myocyte injury in heart failure Heart (British Cardiac Society) 90 2004 1110 1113
22. R. Schulz, J. Rose, C. Martin, O.E. Brodde, and G. Heusch Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation Circulation 88 1993 684 695
23. D.A. Pascual-Figal, S. Manzano-Fernandez, M. Boronat, T. Casas, I.P. Garrido, J.C. Bonaque, F. Pastor-Perez, M. Valdes, and J.L. Januzzi Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure Eur J Heart Fail 13 2011 718 725
24. Y. Xue, P. Clopton, W.F. Peacock, and A.S. Maisel Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure Eur J Heart Fail 13 2011 37 42
25. M. Gheorghiade, W. Gattis Stough, K.F. Adams Jr., A.S. Jaffe, V. Hasselblad, and C.M. O'Connor The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF) Am J Cardiol 96 2005 18G 25G
26. J.R. Teerlink, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg, P. Ponikowski, E. Unemori, A.A. Voors, K.F. Adams Jr., M.I. Dorobantu, L.R. Grinfeld, G. Jondeau, A. Marmor, J. Masip, P.S. Pang, K. Werdan, S.L. Teichman, A. Trapani, C.A. Bush, R. Saini, C. Schumacher, T.M. Severin, and M. Metra Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
27. M. Metra, P. Ponikowski, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg, T.A. Hua, T. Severin, E. Unemori, A.A. Voors, and J.R. Teerlink Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF Eur Heart J 34 2013 3128 3136
28. M. Packer, P.A. Poole-Wilson, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, B.M. Massie, L. Ryden, K. Thygesen, and B.F. Uretsky Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group Circulation 100 1999 2312 2318
29. S. Agewall, E. Giannitsis, T. Jernberg, and H. Katus Troponin elevation in coronary vs. non-coronary disease Eur Heart J 32 2011 404 411